MedWatch

Coloplast drops prior skepticism, agrees to divulge national tax information

After having taken a skeptical position on disclosing how much money Coloplast makes in each country where it operates, the company has now shifted its stance on the matter. Effective from the annual report's release in November, Denmark's largest medical technology company will be more transparent about its tax payments.

Photo: Jacob Ehrbahn/Politiken/Ritzau Scanpix

Denmark's second-largest life science company, Coloplast, will henceforth provide both investors and the general public more insight on where the group pays tax, shows the third-quarter financial statement for its fiscal 2021, published Thursday morning.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Extra data boosts Lundbeck's agitation case

Pharmaceutical firm Lundbeck has presented positive new data at a US conference as it seeks approval for its candidate Rexulti as a treatment for agitation in Alzheimer’s patients.

Further reading

Related articles

Latest news

See all jobs